141,745 Shares in Aspen Aerogels, Inc. $ASPN Bought by Lazard Asset Management LLC

Lazard Asset Management LLC purchased a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) in the 1st quarter, HoldingsChannel reports. The firm purchased 141,745 shares of the construction company’s stock, valued at approximately $485,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Rice Hall James & Associates LLC increased its holdings in shares of Aspen Aerogels by 9.2% in the first quarter. Rice Hall James & Associates LLC now owns 1,552,628 shares of the construction company’s stock worth $5,310,000 after buying an additional 131,023 shares during the period. Public Employees Retirement System of Ohio bought a new position in Aspen Aerogels during the 1st quarter worth approximately $214,000. Hsbc Holdings PLC grew its position in Aspen Aerogels by 350.1% during the 1st quarter. Hsbc Holdings PLC now owns 104,982 shares of the construction company’s stock worth $359,000 after acquiring an additional 81,656 shares during the last quarter. Clarus Group Inc. purchased a new position in Aspen Aerogels in the 1st quarter worth approximately $36,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Aspen Aerogels in the 4th quarter worth approximately $30,000. 97.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ASPN. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Wednesday, June 24th. Wall Street Zen raised shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Barclays upped their price target on shares of Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a report on Monday, May 11th. Finally, Roth Capital reissued a “buy” rating and set a $5.75 price target on shares of Aspen Aerogels in a research report on Friday, May 8th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Aspen Aerogels has a consensus rating of “Hold” and an average target price of $5.19.

Key Aspen Aerogels News

Here are the key news stories impacting Aspen Aerogels this week:

• Positive Sentiment: Improved outlook: Aspen guided for third-quarter 2026 revenue of $65 million to $80 million, well above the roughly $56.6 million analyst consensus, and adjusted EBITDA of $7 million to $15 million. Its expected EPS loss of $0.11 to $0.07 is also better than the $0.13 consensus loss. Aspen Aerogels Second-Quarter Results
• Positive Sentiment: Thermal-barrier momentum: Second-quarter Thermal Barrier revenue reached $29.5 million, an 81% increase from the prior quarter. Aspen also raised its 2026 European Thermal Barrier revenue outlook to $20 million-$30 million, supporting expectations for continued electrification-related growth. Q2 2026 Earnings Call Transcript
• Positive Sentiment: Automotive customer win: Aspen received a PyroThin award from Jaguar Land Rover covering two next-generation vehicle architectures. The award reinforces the potential for its battery-safety materials to generate future automotive revenue. Aspen Aerogels Business Highlights
• Neutral Sentiment: Russell 1000 attention: Coverage highlighted Aspen’s Russell 1000 connection, which may increase visibility and trading interest but does not by itself change the company’s fundamentals. Russell 1000 Coverage
• Negative Sentiment: Profitability remains weak: Aspen reported a second-quarter loss of $0.22 per share, only slightly better than the $0.23 consensus estimate and worse than the $0.04 loss a year earlier. The company continues to post negative net margins and return on equity, so the stock remains dependent on successful execution of its growth plans. Aspen Aerogels Q2 Earnings Report

Aspen Aerogels Stock Up 36.6%

Shares of NYSE:ASPN opened at $6.84 on Friday. The stock’s 50-day moving average is $5.51 and its 200 day moving average is $4.41. The company has a market cap of $567.23 million, a PE ratio of -5.03 and a beta of 2.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.89 and a quick ratio of 2.54. Aspen Aerogels, Inc. has a 1 year low of $2.30 and a 1 year high of $9.78.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The business had revenue of $37.88 million during the quarter, compared to analysts’ expectations of $36.58 million. Aspen Aerogels had a negative return on equity of 22.16% and a negative net margin of 48.64%.The company’s quarterly revenue was down 51.8% compared to the same quarter last year. During the same quarter last year, the business posted ($0.06) EPS. Sell-side analysts anticipate that Aspen Aerogels, Inc. will post -0.8 EPS for the current year.

Aspen Aerogels Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.